Defense Health Agency Contracting Activity - DHACA

Description

The vision of the FY13 NFRP is to decrease the clinical impact of NF. Toward this end, the NFRP seeks to: support innovative, high-impact research that will foster new directions for and address neglected issues in NF research; sponsor multidisciplinary and multi-institutional collaborations that will bring new perspectives to the field; foster the next generation of NF investigators; promote translational and clinical studies to move promising ideas from bench to bedside; develop a balanced portfolio of meritorious research related to all aspects of NF1, NF2, and schwannomatosis. Areas of Emphasis: The FY13 NFRP strongly encourages research applications that specifically address the critical needs of the NF community in one or more of the following Areas of Emphasis: • Cognitive and social dysfunction in the setting of NF; • Drug discovery for the treatment of NF; • Heterogeneity of neurofibromas and other NF-related tumors using genomics, epigenetics, systems biology, or other similar approaches; • Manifestations of NF post-adolescence; • Novel disease markers such as imaging and proteomics of NF; • Pain in the setting of NF. The NFRP Investigator-Initiated Research Award supports innovative basic and clinically oriented research that will: • Provide insight into the development of NF, or into particular lesions or abnormalities that occur as a result of NF; • Result in substantial improvements over today’s approach to the diagnosis and treatment of NF; and • Have an impact on the quality of life of persons with NF. Applications must include preliminary or published data that is relevant to NF and the proposed research project.

Who can apply

• Unrestricted

Contact

CDMRP Help Desk <br/>301-682-5507
help@cdmrp.org mil